Suppr超能文献

一项由药剂师主导的干预措施,旨在提高门诊肾移植患者用药的准确性。

A Pharmacist-Driven Intervention Designed to Improve Medication Accuracy in the Outpatient Kidney Transplant Setting.

作者信息

Cohen Elizabeth A, McKimmy Danielle, Cerilli Anna, Kulkarni Sanjay

机构信息

Yale New Haven Transplant Center, Yale New Haven Hospital, New Haven, CT, USA.

Department of Pharmacy, University of Florida Health Shands Hospital, Gainsville, FL, USA.

出版信息

Drug Healthc Patient Saf. 2020 Nov 25;12:229-235. doi: 10.2147/DHPS.S264022. eCollection 2020.

Abstract

BACKGROUND

Medication errors are one of the leading causes of complications and readmissions in healthcare and stem directly from inadequate medication lists. In transplantation, medication discrepancies can lead to fluctuating levels of immunosuppression, resulting in rejection, infection, or drug toxicity.

METHODS

We implemented a pharmacist-driven intervention designed to improve the accuracy of outpatient kidney transplant patients' medication lists in the electronic medical record (EMR). Baseline medication error rates (Phase 1) were collected, and the intervention was a dedicated pharmacist (Phase 2) who performed medication reconciliation with patients. The primary outcome was the percent of patients with inadequate medication reconciliation determined by any one error in medication reconciliation (Phase 1 vs Phase 2). Secondary outcomes included the number of medication errors, of all medications and high-risk medications, identified per patient sample using statistical process control phase analysis.

RESULTS

Pharmacist-driven medication reconciliation significantly reduced medication list discrepancies from 95% to 28% (<0.05). There were a total of 398 errors in the control group and 49 errors in the intervention group. In addition, there were 73 high-risk medication discrepancies in the control group and three in the intervention group. The total number of medication errors decreased post-intervention with a marked reduction in the variation of control limits (LCL, UCL: phase 1, -34.3, 113.9; phase 2, -7.1, 15.3) and average number of medication errors per sample (phase 1, 39.8; phase 2, 14.1). For high-risk medications, phase analysis demonstrated a marked reduction in control limit variation between phases (LCL, UCL: phase 1, -10.4, 25.0; phase 2, -0.5, 0.7) and average number of medication errors per sample (phase 1, 7.3; phase 2, 0.1).

DISCUSSION

A dedicated pharmacist improved medication list accuracy over conventional practice that utilizes transplant nurses and physicians. Further studies into the cost-effectiveness of this strategy should further justify this approach.

摘要

背景

用药错误是医疗保健中并发症和再入院的主要原因之一,直接源于用药清单不完整。在移植领域,用药差异可导致免疫抑制水平波动,从而引发排斥反应、感染或药物毒性。

方法

我们实施了一项由药剂师主导的干预措施,旨在提高门诊肾移植患者电子病历(EMR)中用药清单的准确性。收集了基线用药错误率(第1阶段),干预措施是由一名专职药剂师(第2阶段)与患者进行用药核对。主要结局是用药核对中出现任何一项错误所确定的用药核对不充分的患者百分比(第1阶段与第2阶段)。次要结局包括使用统计过程控制阶段分析在每个患者样本中识别出的所有药物和高风险药物的用药错误数量。

结果

药剂师主导的用药核对显著降低了用药清单差异,从95%降至28%(<0.05)。对照组共有398项错误,干预组有49项错误。此外,对照组有73项高风险用药差异,干预组有3项。干预后用药错误总数减少,控制限的变化显著降低(下限、上限:第1阶段,-34.3,113.9;第2阶段,-7.1,15.3),每个样本的用药错误平均数也减少(第1阶段,39.8;第2阶段,14.1)。对于高风险药物类型,阶段分析表明各阶段之间控制限变化显著降低(下限、上限:第1阶段,-10.4,25.0;第2阶段,-0.5,0.7),每个样本的用药错误平均数也减少(第1阶段,7.3;第2阶段,0.1)。

讨论

与利用移植护士和医生的传统做法相比,专职药剂师提高了用药清单的准确性。对该策略成本效益的进一步研究应能进一步证明这种方法的合理性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/7701366/fba2799c9b3b/DHPS-12-229-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验